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Abstract 
Background: Rapid response system (RRS) is being increasingly adopted to improve patient safety in hospitals 
worldwide. However, predictors of survival outcome after RRS activation because of unexpected clinical deterioration 
are not well defined. We investigated whether hospital length of stay (LOS) before RRS activation can predict the clini‑
cal outcomes.
Methods: Using a nationwide multicenter RRS database, we identified patients for whom RRS was activated during 
hospitalization at 9 tertiary referral hospitals in South Korea between January 1, 2016, and December 31, 2017. All 
information on patient characteristics, RRS activation, and clinical outcomes were retrospectively collected by review‑
ing patient medical records at each center. Patients were categorized into two groups according to their hospital LOS 
before RRS activation: early deterioration (LOS < 5 days) and late deterioration (LOS ≥ 5 days). The primary outcome 
was 28‑day mortality and multivariable logistic regression was used to compare the two groups. In addition, propen‑
sity score‑matched analysis was used to minimize the effects of confounding factors.
Results: Among 11,612 patients, 5779 and 5883 patients belonged to the early and late deterioration groups, respec‑
tively. Patients in the late deterioration group were more likely to have malignant disease and to be more severely ill 
at the time of RRS activation. After adjusting for confounding factors, the late deterioration group had higher 28‑day 
mortality (aOR 1.60, 95% CI 1.44–1.77). Other clinical outcomes (in‑hospital mortality and hospital LOS after RRS 
activation) were worse in the late deterioration group as well, and similar results were found in the propensity score‑
matched analysis (aOR for 28‑day mortality 1.66, 95% CI 1.45–1.91).
Conclusions: Patients who stayed longer in the hospital before RRS activation had worse clinical outcomes. Dur‑
ing the RRS team review of patients, hospital LOS before RRS activation should be considered as a predictor of future 
outcome.
© The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which 
permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the 
original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or 
other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line 
to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory 
regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this 
licence, visit http://creat iveco mmons .org/licen ses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creat iveco 
mmons .org/publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Open Access
*Correspondence:  sangmin2@snu.ac.kr
†Jimyung Park and Yeon Joo Lee contributed equally to this work
1 Division of Pulmonary and Critical Care Medicine, Department 
of Internal Medicine, Seoul National University College of Medicine, 101, 
Daehak‑ro, Jongno‑gu, Seoul 03080, Republic of Korea
Full list of author information is available at the end of the article
Page 2 of 10Park et al. Respir Res           (2021) 22:60 
Background
A rapid response system (RRS) is a system designed for 
prompt and appropriate intervention in patients who 
experience unexpected clinical deterioration during hos-
pitalization [1]. Previous studies have shown its efficacy 
in reducing the rates of in-hospital mortality, and the 
implementation of RRS has been increasing worldwide 
in recent decades [2, 3]. Therefore, accurate risk stratifi-
cation is needed for improving the triage of patients and 
resource allocation. However, despite the pervasive use of 
RRS, little is known about how best to predict the clinical 
outcomes of patients for whom RRS is activated. A recent 
study using multicenter registry data reported that, in 
addition to vital signs such as systolic blood pressure and 
respiratory rate, time after admission before RRS activa-
tion is a significant predictor of mortality [4].
Hospital length of stay (LOS) is often used as one 
method for assessing patient outcomes in clinical prac-
tice. It is well known that a longer hospital LOS is associ-
ated with a higher risk of malnutrition and frailty [5, 6]. 
In addition, older patients with poor baseline functional 
status are more likely to stay longer after various elec-
tive surgeries because of postoperative complications [7]. 
Considering that RRS activation occurs in the middle of 
hospitalization while patients are being actively treated, 
hospital LOS before RRS activation may provide a simple 
substitute marker for estimating the effectiveness of past 
treatments and predicting future outcomes. In this study, 
using a large nationwide multicenter database of patients 
reviewed by RRS teams, we aimed to evaluate whether 
hospital LOS before RRS activation can predict the clini-
cal outcomes of patients after adjusting for confounding 
factors associated with the severity of illness.
Methods
Study population
We retrospectively analyzed the medical records of 
patients for whom an RRS call was activated in 9 ter-
tiary referral hospitals in South Korea between Janu-
ary 1, 2016, and December 31, 2017. Patients older than 
18 years for whom RRS was activated during hospitaliza-
tion were eligible for this study and screened using the 
RRS database for each center. We included every eligible 
patient whose time after admission before RRS activa-
tion was ≤ 1 month. If there were recurrent RRS calls in 
one patient, the first circumstance of RRS activation was 
included in the analysis of this study. The study protocol 
was reviewed and approved by the institutional review 
board of each center and informed consent was waived.
Implementation of RRS
Although the detailed protocols of RRS differed between 
centers, all centers used the vital signs or certain labora-
tory results for in-ward patients to screen and identify 
patients at risk of clinical deterioration. In addition, calls 
from medical staff members on the ward, including doc-
tors and nurses, were also used to identify patients whose 
clinical situation was worsening, even if they did not 
meet the specific activation criteria, and the RRS team 
was dispatched if needed. The detailed RRS activation 
criteria are summarized in the Additional file 1: Appen-
dix S1.
Study outcomes and data collection
The primary outcome of our study was 28-day mortality. 
For secondary outcomes, we evaluated in-hospital mor-
tality, admission to the intensive care unit (ICU), hos-
pital LOS after RRS activation, and LOS in the ICU for 
patients admitted to the ICU. Data were collected retro-
spectively by reviewing patient medical records at each 
participating center. Detailed information regarding the 
situation when RRS was activated was collected. In addi-
tion to the interventions carried out by the RRS team, we 
also checked whether discussion of a do-not-resuscitate 
(DNR) order was made after RRS activation. The sever-
ity of illness at the time of RRS activation was evaluated, 
and the modified early weaning score (MEWS) and the 
national early warning score 2 (NEWS2) were calculated 
for each patient.
Statistical analysis
To evaluate the effects of hospital LOS before RRS activa-
tion on the clinical outcomes, we categorized the patients 
according to their days since admission before RRS acti-
vation. We divided patients into two groups (early dete-
rioration vs. late deterioration groups) by dichotomizing 
hospital LOS before RRS activation with the median 
value. Differences between groups were analyzed using 
the Mann–Whitney U test or Pearson’s chi-squared test, 
as appropriate. P values < 0.05 for two-tailed tests were 
considered to be statistically significant.
Mortality outcomes and rates of admission to the 
ICU were compared between the early and late dete-
rioration groups using a multivariable logistic regression 
and adjusted odds ratios (aORs) with 95% confidence 
Keywords: Hospital rapid response team, Clinical deterioration, Length of stay, Mortality, General ward, Intensive care 
units
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intervals (CIs) were calculated. We selected relevant 
clinical variables to adjust for that showed significant 
associations with mortality outcomes. Missing variables 
were handled with multiple imputation methods [8]. 
Outcomes related to LOS (hospital LOS after RRS acti-
vation and LOS in the ICU for patients admitted to the 
ICU) were analyzed using a negative binomial regression 
to calculate the adjusted incidence rate ratios (aIRRs).
Even after using multivariable regression models to 
compare clinical outcomes between the early and late 
deterioration groups, we expected some remaining con-
founding factors to be present because the two groups 
would be clinically different. Therefore, we performed 
propensity score-matched analysis to reduce the effects 
of possible confounding factors as much as possible [9]. 
After calculating propensity score (late vs. early dete-
rioration), we conducted 1:1 optimal matching without 
replacement [10]. A more detailed description of the 
analysis is available in the Additional file 1: Appendix S2. 
Using matched samples, we calculated unadjusted and 
adjusted ORs to assess the associations between binary 
outcomes and LOS before RRS activation using a condi-
tional logistic regression model for matched data [11, 12]. 
For continuous outcomes, the Wilcoxon signed-rank test 
was used to compare between matched samples.
We also performed several sensitivity analyses. First, 
we included the patients who were excluded in the 
main analysis because RRS was activated after 1  month 
of admission to evaluate whether our inclusion criteria 
affected the study results. Second, we conducted analysis 
with only patients without missing data to exclude pos-
sible bias due to the multiple imputation methods used to 
handle missing data. Third, patients in whom discussion 
on DNR orders occurred were excluded for the analysis. 
Fourth, the same analyses were repeated with handling 
hospital LOS as a continuous variable, instead of catego-
rizing patients into early and late deterioration groups, to 
examine the robustness of our results. Fifth, we catego-
rized patients into four quartile groups using the inter-
quartile range (IQR) values for the hospital LOS before 
RRS activation. Then, we evaluated whether there was a 
proportional relationship between the LOS before RRS 
activation and mortality outcomes.
For the primary outcome (28-day mortality), prespeci-
fied subgroup analyses with tests for interactions were 
performed. We compared the effects of hospital LOS on 
the clinical outcomes between subgroups according to 
the patient’s department of admission (medical vs. sur-
gical) and whether the patient had undergone a surgical 
operation before RRS activation. In addition, we analyzed 
the subgroup of patients for whom RRS was activated 
through use of the screening criteria (i.e. not by calls 
from in-ward medical staff members). We also conducted 
subgroup analyses for three key comorbidities (solid can-
cer, hematological malignancy, and chronic lung disease). 
All statistical analyses were performed using STATA soft-




During the 2-year study period, a total of 12,803 patients 
had RRS activation in 9 participating centers. Of these 
patients, 1191 were excluded because RRS activation 
occurred > 1  month after admission to the hospital and 
11,612 patients were included in our analysis (Fig.  1). 
The excluded patients were younger and had lower BMI. 
They were also more likely to be admitted for surgi-
cal operation or hematological malignancy (Additional 
file 1: Table S1). The median number of days after admis-
sion before RRS activation was 5 (IQR 2–10) (Additional 
file 1: Fig. S1). Using a cutoff value of 5 days, we divided 
patients into two groups: an early deterioration group 
(LOS before RRS activation < 5  days, N = 5779) and a 
late deterioration group (LOS before activation ≥ 5 days, 
N = 5883).
The baseline characteristics were compared between 
these two groups and are summarized in Table 1. Patients 
in the early deterioration group were more likely to be 
admitted to a medical department than a surgical depart-
ment, and significantly more patients in the late deterio-
ration group underwent a surgical operation before RRS 
activation during their hospitalization. The comorbidi-
ties differed between the two groups. Particularly, malig-
nant disease was more common in the late deterioration 
group, whereas chronic lung disease was more frequent 
in the early deterioration group.
RRS activations
Information about the context of RRS is described in 
Additional file 1: Table S2. The most common assessment 
made by the RRS team was respiratory distress (35.1%). 
At the time of RRS activation, more severely ill patients 
were included in the late deterioration group. Hence, 
interventions delivered by the RRS team also differed 
between the two groups (Table 2). Notably, discussion on 
DNR orders occurred significantly more frequently in the 
late deterioration group.
Outcomes in relation to the hospital LOS before RRS 
activation
Data on primary and secondary outcomes are summa-
rized in Table 3. Overall, 2534 of 11,612 patients (21.8%) 
had died by 28  days after RRS activation: 1051 of 5779 
patients (18.2%) in the early deterioration group and 
1483 of 5833 patients (25.4%) in the late deterioration 
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group (aOR 1.60; 95% CI 1.44–1.77). The effects of other 
adjusted variables are described in Additional file  1: 
Table S3. Similar results were observed in the analysis of 
in-hospital mortality with a higher mortality rate in the 
late deterioration group (20.9% vs. 30.2%, aOR 1.71; 95% 
CI 1.55–1.88). Other clinical outcomes (ICU admission, 
hospital LOS after RRS activation, and LOS in the ICU) 
were all worse in the late deterioration group.
Propensity score‑matched analysis
Among these 10,149 patients who had no missing data 
for the prespecified variables for the propensity model, 
4454 patients were 1:1 matched for each of the early and 
late deterioration groups. The distribution of the propen-
sity scores in the two groups is depicted in Additional 
file 1: Fig S2. The matched groups were shown to be well 
balanced in baseline characteristics (Additional file  1: 
Table S4), except that more patients in the late deteriora-
tion group underwent a surgical operation during hospi-
talization before RRS activation (standardized difference 
11.1%).
The results of analysis of the propensity score-
matched samples are summarized in Table  4. The asso-
ciations between mortality outcomes and hospital LOS 
before RRS activation were similar to those found in the 
unmatched analysis. The late deterioration group had a 
significantly higher rates of 28-day mortality (aOR 1.66; 
95% CI 1.45–1.91) and in-hospital mortality (aOR 1.72; 
95% CI 1.51–1.95), which showed similar aOR values as 
in the unmatched analysis.
Sensitivity analysis
Several sensitivity analyses showed the robustness 
of the results of our main analysis (Additional file  1: 
Table  S5–9). Particularly, when hospital LOS was han-
dled as a continuous variable in the regression analy-
sis, 1-day increase in hospital LOS was associated with 
worsening of all clinical outcomes, consistent with the 
results of main analysis. Then, we performed further 
analysis after dividing patients into four quartiles (Qs) 
according to their hospital LOS before RRS activation: 
Q1 (N = 2273, < 2  days); Q2 (N = 3506, 2–4  days); Q3 
(N = 2620, 5–9 days); and Q4 (N = 3213, ≥ 10 days). Both 
aORs for 28-day mortality and in-hospital mortality 
showed an increasing tendency with longer hospital LOS 
before RRS activation (Fig. 2).
Subgroup analysis
Prespecified subgroup and interaction-term analyses 
were performed to investigate possible effect modifiers 
(Fig. 3). There was a significant interaction between the 
department of admission (medical vs. surgical) and the 
effects of hospital LOS on 28-day mortality (P = 0.047 for 
interaction). The negative impact of longer hospital LOS 
Fig. 1 Flowcharts of patients included in the study
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before RRS activation was stronger for patients admit-
ted to the surgical department. A similar interaction was 
also observed when comparing patients who underwent 
a surgical operation and those who did not (P = 0.006 
for interaction). For other subgroup analyses, there were 
no significant between-group differences in the primary 
outcome.
Discussion
In this study, we found that longer hospital LOS before 
RRS activation was associated with worse clinical out-
comes. Patients who stayed ≥ 5  days before RRS activa-
tion had higher 28-day and in-hospital mortality rates 
and were more likely to stay longer in the hospital after 
RRS activation compared with those who stayed < 5 days. 
This finding was robust after adjusting for variables 
reflecting the severity of illness at the time of RRS activa-
tion and even after propensity score-matched analysis.
The effectiveness of RRS has been studied extensively 
in the past two decades. Although early studies includ-
ing cluster randomized trials failed to show significant 
reduction in mortality [13, 14], many other studies, such 
as before and after studies, have consistently shown posi-
tive results, as demonstrated in recent systematic review 
and meta-analysis studies [2, 15]. However, in real-world 
practice, when implementing RRS, it is difficult to predict 
clinical outcomes of individual patients for whom RRS 
activated because a wide range of patients with various 
comorbidities are being reviewed by the RRS team.
Certain alarming vital signs or laboratory test abnor-
malities are usually used as screening tools for RRS 
activation [16]. However, when two different patients 
with similar vital signs are reviewed by the RRS team, 
the expected outcomes may differ according to the 
patients’ current illness and comorbidities. As the vol-
ume of cases reviewed by the RRS team increases, it is 
important to be able to predict the clinical outcome to 
improve the cost-effectiveness and optimize resource 
use. This also relates to the decision about which 
patients should be admitted to the ICU when available 
beds and resources are limited. Patients who have a 
higher probability of recovery are usually given a higher 
Table 1 Patient characteristics
RRS rapid response system, LOS length of stay
a Postoperative days are summarized for only patients who were admitted and received a surgical operation
Variables Total Early Late P value
patients deterioration deterioration
(N = 11,612) (N = 5779) (N = 5833)
Age (year) 68 (57–76) 68 (57–77) 67 (57–76) 0.288
Sex
 Male 6785 (58.4%) 3265 (56.5%) 3520 (60.4%)  < 0.001
 Female 4827 (41.6%) 2514 (43.5%) 2313 (39.6%)
Body mass index (kg/m2) 22.2 (19.6–25.0) 22.3 (19.8–25.0) 22.2 (19.5–24.9) 0.012
Admission department
 Medical 8160 (70.3%) 4120 (71.3%) 4040 (69.3%) 0.017
 Surgical and obstetrical 3452 (29.7%) 1659 (28.7%) 1793 (30.7%)
 Surgical operation 2867 (24.7%) 1050 (18.2%) 1817 (31.2%)  < 0.001
 Before RRS activation
 Postoperative  daysa (days) 3 (1–7) 1 (0–2) 5 (3–10)  < 0.001
Comorbidity
 Solid cancer 4646 (40.0%) 2238 (38.7%) 2408 (41.3%) 0.005
 Hematological malignancy 1002 (8.6%) 336 (5.8%) 666 (11.4%)  < 0.001
 Cardiovascular disease 2715 (23.4%) 1323 (22.9%) 1392 (23.9%) 0.216
 Diabetes mellitus 3132 (27.0%) 1520 (26.3%) 1612 (27.6%) 0.105
 Chronic lung disease 1687 (14.5%) 909 (15.7%) 778 (13.3%)  < 0.001
 Hepatobiliary disease 1297 (11.2%) 640 (11.1%) 657 (11.3%) 0.747
 Chronic kidney disease 1251 (10.8%) 590 (10.2%) 661 (11.3%) 0.051
 Cerebrovascular disease 1329 (11.5%) 585 (10.1%) 744 (12.8%)  < 0.001
 Organ transplantation 356 (3.1%) 128 (2.2%) 228 (3.9%)  < 0.001
Hospital LOS before 5 (2–10) 2 (1–3) 10 (7–17)  < 0.001
RRS activation (days)
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priority for ICU admission [17]. However, it is difficult 
for RRS staff members to review the functional status 
and detailed medical history of patients and assess the 
likelihood of recovery in a short time.
In this regard, attention has been focused on efforts 
to identify predictors of clinical outcomes for patients 
for whom RRS is activated. A prospective observational 
study reported that assessment of frailty would be help-
ful for predicting the clinical trajectory of patients [18]. 
We hypothesized that hospital LOS before RRS activa-
tion may be a useful and simple predictor of clinical 
outcome after considering that severe frailty is usually 
associated with longer LOS [5]. In two previous single-
center studies that evaluated the effect of LOS before 
RRS activation on clinical outcomes, the late deteriora-
tion group (≥ 7 days) had more than twice the in-hos-
pital mortality rate than the early deterioration group 
(< 2 days) [19, 20]. However, those studies did not fully 
adjust for between-group differences in their analyses.
A study using the nationwide multicenter registry in 
the USA, which included about 280,000 patients, dem-
onstrated that hours since admission before RRS activa-
tion was the second most important factor, after systolic 
blood pressure, in predicting in-hospital mortality [4]. 
However, a limitation of that study was that patients’ 
underlying comorbidities were categorized too simply as 
either medical or surgical and either cardiac or noncar-
diac. A detailed history of underlying comorbidities is a 
critical factor affecting the outcome, as shown in a recent 
study that reported an in-hospital mortality rate of > 40% 
in patients with hematological malignancy for whom RRS 
was activated [21].
In this study, we found that time since admission before 
RRS activation was an independent significant predictor 
of clinical outcome. A longer LOS before RRS activa-
tion itself may suggest ineffectiveness of the initial treat-
ment and reflect the severity of the illness that caused 
the patient to be admitted. Therefore, among the patients 
Table 2 Severity of illness at RRS activation and interventions by RRS team
RRS rapid response system, MEWS modified early weaning score, NEWS2 national early warning score 2, SOFA sequential organ failure assessment, ACLS advanced 
cardiac life support, CPR cardiopulmonary resuscitation, ECLS extracorporeal life support
a SOFA scores were available in 6,733 (58.0%) patients who had relevant laboratory test results including arterial blood gas analysis
Variables Total Early Late P value
patients deterioration deterioration
(N = 11,612) (N = 5779) (N = 5833)
Mean blood pressure (mmHg) 83 (66–98) 82 (66–97) 83 (66–98) 0.289
Heart rate (rate/min) 102 (84–120) 100 (82–120) 104 (86–122)  < 0.001
Respiratory rate (rate/min) 22 (18–28) 22 (18–28) 22 (18–28) 0.46
Body temperature (°C) 36.9 (36.5–37.6) 36.9 (36.5–37.6) 36.9 (36.5–37.6) 0.36
Alert mental status 7968 (68.6%) 4204 (72.8%) 3764 (64.5%)  < 0.001
Need for supplementary oxygen therapy 6880 (59.3%) 3339 (57.8%) 3541 (60.7%) 0.001
MEWS 4 (2–5) 4 (2–5) 4 (2–6)  < 0.001
NEWS2 7 (5–10) 7 (5–10) 8 (5–10)  < 0.001
SOFA  scorea 5 (3–7) 4 (2–7) 5 (3–8)  < 0.001
Intervention of RRS team
Tracheal intubation 1525 (13.1%) 720 (12.5%) 805 (13.8%) 0.032
Mechanical ventilation 1400 (12.1%) 655 (11.3%) 745 (12.8%) 0.017
High flow nasal cannula 900 (7.8%) 458 (7.9%) 442 (7.6%) 0.484
Noninvasive ventilation 172 (1.5%) 103 (1.8%) 69 (1.2%) 0.008
Renal replacement therapy 499 (4.3%) 241 (4.2%) 258 (4.4%) 0.501
ACLS including CPR 453 (3.9%) 201 (3.5%) 252 (4.3%) 0.019
ECLS 49 (0.4%) 26 (0.5%) 23 (0.4%) 0.644
Central venous catheter 831 (7.2%) 415 (7.2%) 416 (7.1%) 0.918
Antimicrobial therapy 745 (6.4%) 325 (5.6%) 420 (7.2%) 0.001
Vasopressor/inotrope 1443 (12.4%) 705 (12.2%) 738 (12.7%) 0.46
Transfusion 659 (5.7%) 307 (5.3%) 352 (6.0%) 0.093
Discussion regarding 1226 (10.6%) 541 (9.4%) 685 (11.7%)  < 0.001
do‑not‑resuscitate order
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with long hospital LOS at the time of RRS activation, 
invasive treatment, such as mechanical ventilation, may 
be deemed as futile in a certain proportion of patients. 
This is reflected by our finding that more patients in the 
late deterioration group had discussion with RRS staff 
members regarding the DNR order. Although attending 
physicians have a principal role in communicating with 
patients and their family members, the intervention of a 
third party, the RRS team, may improve end-of-life care 
planning by avoiding unnecessary or futile invasive treat-
ment [22, 23].
The association between longer hospital LOS and 
worse clinical outcomes may indicate that medical 
problems acquired in the hospital setting are usually 
more serious, particularly for infectious complications 
[24]. This is because patients with hospital-acquired 
infection are at higher risk of infection with multid-
rug resistant pathogens. In our subgroup analysis, it 
was noted that the negative effects of longer hospital 
LOS on the clinical outcomes were more significant 
in patients who were admitted to surgical department 
or underwent a surgical operation. Given that postop-
erative wound infection or pneumonia are common 
Table 3 Effects of  the  hospital LOS before  RRS activation 
on the clinical outcomes
LOS length of stay, RRS rapid response system, OR odds ratio, IRR incidence rate 
ratio, ICU intensive care unit
a Multivariable logistic regression and negative binomial regression were 
performed with adjusting for following confounding variables: age, department 
of admission (medical vs. surgical), whether patients were in postoperative 
state, comorbidities of solid cancer, hematological malignancy, chronic lung 
disease, hepatobiliary disease, or cerebrovascular disease, whether DNR (do-not-
resuscitate) discussion was made after RRS activation, and NEWS2 (national early 
warning score 2)









28‑day mortality 1051 (18.2%) 1483 (25.4%)
Unadjusted OR 1.00 1.53 (1.40–1.68)  < 0.001
Adjusted  OR1 1.00 1.60 (1.44–1.77)  < 0.001
Secondary outcome
In‑hospital mortality 1209 (20.9%) 1758 (30.2%)
Unadjusted OR 1.00 1.63 (1.50–1.78)  < 0.001
Adjusted  ORa 1.00 1.71 (1.55–1.88)  < 0.001
ICU admission 1611 (27.9%) 1774 (30.4%)
Unadjusted OR 1.00 1.13 (1.04–1.23) 0.003
Adjusted  ORa 1.00 1.10 (1.01–1.20) 0.030
Hospital LOS after RRS 
activation (days)
10 (5–20) 14 (6–27)
Unadjusted IRR 1.00 1.33 (1.28–1.38)  < 0.001
Adjusted  IRRa 1.00 1.30 (1.25–1.35)  < 0.001
LOS in  ICUb (days) 4 (2–9) 5 (3–10)
Unadjusted IRR 1.00 1.21 (1.13–1.30)  < 0.001
Adjusted  IRRa 1.00 1.22 (1.14–1.31)  < 0.001
Table 4 Analysis in  the  propensity score-based 1:1 
matched patients
LOS length of stay, RRS rapid response system, OR odds ratio, IRR incidence rate 
ratio, ICU intensive care unit
a To minimize effects of remaining confounding factors after matching, 
adjusted analyses were also performed. Following variables were adjusted: 
age, department of admission (medical vs. surgical), whether patients were in 
postoperative state, comorbidities of solid cancer, hematological malignancy, 
chronic lung disease, hepatobiliary disease, or cerebrovascular disease, whether 
DNR (do-not-resuscitate) discussion was made after RRS activation, and NEWS2 
(national early warning score 2)
b Analysis on LOS in ICU included only patients who were admitted to the ICU
c P values were calculated by conditional logistic regression for binary outcomes 








28‑day mortality 859 (19.3%) 1108 (24.9%)
Unadjusted OR 1.00 1.39 (1.26–1.54)  < 0.001
Adjusted  OR1 1.00 1.66 (1.45–1.91)  < 0.001
Secondary outcome
In‑hospital mortality 999 (22.5%) 1309 (29.4%)
Unadjusted OR 1.00 1.45 (1.31–1.59)  < 0.001
Adjusted  ORa 1.00 1.72 (1.51–1.95)  < 0.001
ICU admission 1325 (29.8%) 1362 (30.6%)
Unadjusted OR 1.00 1.04 (0.95–1.14) 0.392
Adjusted  ORa 1.00 1.10 (0.99–1.22) 0.080
Hospital LOS after 
RRS activation 
(days)
11 (5–21) 14 (6–27)  < 0.001
LOS in  ICUb (days) 4 (2–9) 5 (3–10) 0.305
Fig. 2 Adjusted odds ratio for 28‑day mortality and in‑hospital 
mortality according to quartile groups
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problems leading to delay in discharge in surgical 
patients, these findings may be related to postoperative 
in-hospital infections due to difficult-to-treat patho-
gens [25].
Our study has several limitations. First, because of its 
retrospective observational design, we cannot exclude the 
possible effects of other unmeasured confounding fac-
tors. However, we found consistent results for the main 
analysis, propensity score-matched analysis, and several 
sensitivity analyses, which supports the robustness of 
our results. Second, we could not match every variable 
completely in our propensity score-matched analysis. 
Especially, the standardized difference between matched 
groups in the proportion of patients who underwent 
a surgical operation before RRS activation was 11.1%. 
Thus, we double adjusted the confounding variables to 
minimize the confounding effects [11]. Furthermore, we 
performed a subgroup analysis according to whether the 
patient received a surgery. Third, a causal relationship 
cannot be inferred between hospital LOS before RRS 
activation and later clinical outcomes. Despite these limi-
tations, we believe that hospital LOS at the time of RRS 
activation may provide a simple and reliable prognostic 
information on future outcomes.
Conclusions
In conclusion, among patients for whom RRS was acti-
vated for unexpected clinical deterioration during hospi-
talization, those who stayed longer in the hospital before 
RRS activation had a higher mortality rate than those 
who stayed a shorter time. For improving resource allo-
cation without undermining the probability of recovery, 
a careful review of the reversibility of the patients should 
be performed in patients with a long hospital LOS at the 
time of RRS activation.
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